You are currently viewing a new version of our website. To view the old version click .

Cardiovascular Effects of COVID-19: Acute and Chronic

This special issue belongs to the section “COVID Clinical Manifestations and Management“.

Special Issue Information

Dear Colleagues,

COVID had a significant impact on patients with cardiovascular disease as well as the entire cardiovascular community.  The direct effects of COVID on acute coronary syndromes including STEMI and thrombotic complications including DVT’s, pulmonary embolism as well as microvascular thrombi that occurred in multiple vascular distributions have been well documented. The cardiovascular community was also impacted by the indirect effects which included the public health measures implemented which resulted in hospital avoidance, decreases in compliance with cardiovascular medications and reduction in cardiovascular testing and procedures that was quite dramatic. While many of these direct and indirect effects of COVID have improved, we continue to see the impact in patients with long COVID, a complex syndrome with components of both inflammation and microvascular dysfunction. In this special issue we will highlight  both the acute and the chronic effects of COVID on cardiovascular disease.

Dr. Timothy D. Henry
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. COVID is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • microthrombi
  • STEMI
  • long COVID
  • COVID related acute coronary syndromes
  • cardiovascular effects of COVID
  • biology
  • immune response
  • genetics
  • endothelial health

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
COVID - ISSN 2673-8112